SPECIAL NOTICE
M -- Request for Information (RFI) in support of the National Institute of Allergy and Infectious Diseases (NIAID) Expert Emergency Clinical Research Response
- Notice Date
- 12/12/2017
- Notice Type
- Special Notice
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E128, Rockville, Maryland, 20852, United States
- ZIP Code
- 20852
- Solicitation Number
- S18-035
- Archive Date
- 1/6/2018
- Point of Contact
- Scott P. Keasey, Phone: 301-846-1115, Mary Dixon,
- E-Mail Address
-
scott.keasey@nih.gov, Mary.Dixon@fnlcr.nih.gov
(scott.keasey@nih.gov, Mary.Dixon@fnlcr.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- National Institutes of Health, National Cancer Institute, Frederick National Laboratory for Cancer Research Opportunities-Special Announcements: This Special Notice is not a formal Invitation for Bid (IFB), Request for Proposal (RFP), Request for Quotation (RFQ) nor any type of solicitation for offers. In accordance with FAR 15.201(d), this special notice is intended FOR INFORMATIONAL PURPOSES ONLY in order to: 1) publicize the requirements of the Frederick National Laboratory for Cancer Research (FNLCR); and 2) increase participation by qualified HUBZone small business, small, small disadvantaged, women-owned small business, veteran-owned small business and service-disabled veteran-owned small business concerns, as applicable. The FNLCR is a Government-Owned Contractor-Operated (GOCO) Federally Funded Research and Development Center (FFRDC) located at Fort Detrick, Maryland. The FNLCR partners with university, government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS. FNLCR is a multi-program laboratory currently operated by Leidos Biomedical Research Inc. (Leidos Biomed) for the National Cancer Institute (NCI) under Prime Contract No. HHSN261201500003I, which provides Operations and Technical Support (OTS) for the Frederick National Lab. The Government assumes no liability for reimbursement for any effort or associated costs to respond, nor for any information provided as a result of this notice as no information is being requested. Please be advised that any submissions provided despite the aforementioned notice that no information is requested become Government property and will not be returned, nor will there be any ensuing discussions or debriefings of any responses. Responses submitted to this notice are not offers and cannot be accepted by the U.S. Government to form a binding contract. It is the responsibility of the interested parties to monitor this site and any sites referenced herein for additional information pertaining to business opportunities with the FNLCR, if any. Background Information: The requirements described herein are intended to provide the capacity to proactively identify and establish administrative, operational and management support services in anticipation of future emerging/re-emerging disease outbreaks. Through this proactive, rapid expert approach, Leidos Biomed expects that the time to enroll study participants and reach endpoint analysis can be greatly condensed. Description of Work: Resulting from this RFI, Leidos Biomed intends to identify market sources to form a pool of firms that may possess the capabilities to rapidly deploy and support various clinical research efforts. Firms may be invited to respond to a future IDIQ Request for Proposal. Subsequent awards, if any, may include one or more firms along with their respective teaming partners.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/S18-035/listing.html)
- Record
- SN04764815-W 20171214/171212231459-7e54472677925ce7d7cc2e4067c52577 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |